Giuseppe Bertuglia

7PUBLICATIONS
62CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyGene and molecular therapyMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 11, 2026
Genetic Evidence against Clonotypic B Lymphocytes as a Reservoir for Plasma-cell Cancers.

Carmen González, Juan-Jose Garces, Hector Gracia

|Feb 03, 2025
Efficacy and Prognostic Indicators of Isatuximab, Pomalidomide, and Dexamethasone (IsaPd) in Daratumumab-Refractory Multiple Myeloma Patients: A Multicenter Real-World Study.

Enrica Antonia Martino, Daniele Derudas, Elena Rossi

|Nov 15, 2024
M-protein-related necrobiotic granuloma in a multiple myeloma patient treated with daratumumab, lenalidomide and dexamethasone.

Giuseppe Bertuglia, Sara Bringhen, Benedetto Bruno

|Jul 19, 2024
Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.

Bachisio Ziccheddu, Claudia Giannotta, Mattia D'Agostino

|May 31, 2024
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.

Enrica Antonia Martino, Salvatore Palmieri, Monica Galli

|Dec 04, 2023
Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.

Mattia D'Agostino, Giuseppe Bertuglia, Delia Rota-Scalabrini

Pageof 2

Frequent Collaborators

3 joint publications

Benedetto Bruno

2 joint publications

Giuseppe Mele

2 joint publications

Sara Bringhen

2 joint publications

Paolo Corradini